Simplify Health Care ETF (PINK) Dividend Yield, History & Forecast

Simplify Health Care ETF (PINK) is an exchange-traded fund (ETF) listed on the New York Stock Exchange Arca. It pays a current dividend yield of 0.63% ($0.25 per share annually (TTM)). The most recent ex-dividend date was June 25, 2026, with payment scheduled for June 30, 2026. market capitalization is approximately $151M.

PINK fund composition

PINK holds 58 positions, with 57.1% of assets in its ten largest. It charges an expense ratio of 0.51%, and manages $382.7M.

Top 10 holdings

HoldingWeight
LLYLILLY ELI + CO NPV9.43%
TMOTHERMO FISHER SCIENTIFIC IN USD 1.06.82%
PCTPURECYCLE TECHNOLOGIES I USD 0.00016.76%
UTHRUNITED THERAPEUTICS CORP D USD 0.016.59%
JAZZJAZZ PHARMACEUTICALS PLC USD 0.00015.02%
WRBYWARBY PARKER INC USD 0.00014.92%
JNJJOHNSON + JOHNSON USD 1.04.74%
UNHUNITEDHEALTH GROUP INC USD 0.014.69%
ABBVABBVIE INC USD 0.014.40%
AVTRAVANTOR INC USD 0.013.71%

Sector allocation

Healthcare92.7%Industrials7.3%Consumer Cyclical4.1%Cash & Others0.0%Financial Services0.0%

Frequently Asked Questions about Simplify Health Care ETF (PINK)

What is Simplify Health Care ETF's dividend yield?
Simplify Health Care ETF (PINK) pays a current trailing twelve-month dividend yield of 0.63%, which works out to $0.25 per share annually based on the most recent payout schedule.
When does Simplify Health Care ETF pay distributions?
The most recent ex-dividend date was June 25, 2026. The next scheduled dividend payment date is June 30, 2026.
How many years has Simplify Health Care ETF increased its dividend?
Simplify Health Care ETF (PINK) has increased its dividend for 1 consecutive year.
What does Simplify Health Care ETF invest in?
The Simplify Health Care ETF, identified by its symbol PINK, is engineered to generate significant long-term capital appreciation. It offers investors diversified exposure to pioneering and innovative companies of varying market capitalizations across crucial healthcare sub-sectors, including biotechnology, medical technology, gene therapy, and other rapidly expanding health-related industries. The fund is expertly managed by Michael Taylor, who serves as the lead portfolio manager, bringing more than two decades of specialized experience in overseeing long/short healthcare equity portfolios...